Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 14685170)

1.

Met, metastasis, motility and more.

Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.

Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25. Review. No abstract available.

PMID:
14685170
2.

Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.

Kirchhofer D, Yao X, Peek M, Eigenbrot C, Lipari MT, Billeci KL, Maun HR, Moran P, Santell L, Wiesmann C, Lazarus RA.

J Biol Chem. 2004 Sep 17;279(38):39915-24. Epub 2004 Jun 24.

3.

The MET receptor tyrosine kinase in invasion and metastasis.

Benvenuti S, Comoglio PM.

J Cell Physiol. 2007 Nov;213(2):316-25. Review.

PMID:
17607709
4.

Invasive growth: a genetic program.

Gentile A, Comoglio PM.

Int J Dev Biol. 2004;48(5-6):451-6. Review.

5.

The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

van der Voort R, Taher TE, Derksen PW, Spaargaren M, van der Neut R, Pals ST.

Adv Cancer Res. 2000;79:39-90. Review.

PMID:
10818677
6.

MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.

Higuchi T, Orita T, Katsuya K, Yamasaki Y, Akiyama K, Li H, Yamamoto T, Saito Y, Nakamura M.

Mol Cell Biol. 2004 Sep;24(17):7456-68.

7.

Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.

Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA.

J Mol Biol. 2009 Jan 9;385(1):79-90. doi: 10.1016/j.jmb.2008.09.091. Epub 2008 Oct 15.

PMID:
18973760
8.

The biological role of HGF-MET axis in tumor growth and development of metastasis.

Lesko E, Majka M.

Front Biosci. 2008 Jan 1;13:1271-80. Review.

PMID:
17981628
9.

Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor.

Mood K, Saucier C, Bong YS, Lee HS, Park M, Daar IO.

Mol Biol Cell. 2006 Sep;17(9):3717-28. Epub 2006 Jun 14.

11.

Targeting the c-MET signaling pathway for cancer therapy.

Liu X, Yao W, Newton RC, Scherle PA.

Expert Opin Investig Drugs. 2008 Jul;17(7):997-1011. doi: 10.1517/13543784.17.7.997 . Review.

PMID:
18549337
12.

Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth.

Bertotti A, Comoglio PM, Trusolino L.

J Cell Biol. 2006 Dec 18;175(6):993-1003. Epub 2006 Dec 11.

13.

Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.

Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K.

Int J Cancer. 2007 Nov 1;121(9):1919-29.

PMID:
17621632
14.

HGF/SF-Met signaling in tumor progression.

Gao CF, Vande Woude GF.

Cell Res. 2005 Jan;15(1):49-51. Review.

15.

Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.

Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R.

Am J Physiol Lung Cell Mol Physiol. 2007 Jun;292(6):L1488-94. Epub 2007 Feb 23.

16.

A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met.

Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P.

J Biol Chem. 2008 Jul 25;283(30):21267-77. doi: 10.1074/jbc.M800727200. Epub 2008 May 21.

17.

Caspase cleavage of the MET receptor generates an HGF interfering fragment.

Deheuninck J, Foveau B, Goormachtigh G, Leroy C, Ji Z, Tulasne D, Fafeur V.

Biochem Biophys Res Commun. 2008 Mar 14;367(3):573-7. doi: 10.1016/j.bbrc.2007.12.177. Epub 2008 Jan 8.

PMID:
18187039
18.

Met activation and receptor dimerization in cancer: a role for the Sema domain.

Wickramasinghe D, Kong-Beltran M.

Cell Cycle. 2005 May;4(5):683-5. Epub 2005 May 25. Review.

19.

Expression of c-Met proto-oncogene in metastatic macrophage x melanoma fusion hybrids: implication of its possible role in MSH-induced motility.

Chakraborty AK, Kolesnikova N, Sousa Jde F, Espreafico EM, Peronni KC, Pawelek J.

Oncol Res. 2003;14(3):163-74.

PMID:
14760865
20.

The Sema domain of Met is necessary for receptor dimerization and activation.

Kong-Beltran M, Stamos J, Wickramasinghe D.

Cancer Cell. 2004 Jul;6(1):75-84.

PMID:
15261143
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk